Business
Exercise period extension existing Share Options
Exercise period extension existing Share Options.
About this update from Oxford Biodynamics Plc
[{"type":"text","content":"\n \nRNS Number : 1899Z Oxford BioDynamics PLC 13 December 2017 \n\n \n \n \n \n \nOxford BioDynamics Plc\n(\"OBD\" or the \"Company\" and, together with its subsidiaries, the \"Group\")\n \nExercise period extension of existing Share Options \n \n13 December 2017, Oxford BioDynamics Plc (\"OBD\" or the \"Company\"), a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, announces an amendment to the exercise period for certain options over ordinary shares granted under its 2008 Share Option Scheme.\n \nAs disclosed in the Company's AIM Admission Document dated 1 December 2016 (Part 7, paragraph 10.3 and 10.4) (\"Admission Document\"), EMI (\"EMI Options\") and non-EMI (\"Non-EMI Options\") share options were granted to, amongst others, certain founders of the Company, being Christian Hoyer Millar (Chief Executive Officer and a Director), Dr. Alexandre Akoulitchev (Chief Scientific Officer and a Director) and Dr. Aroul Ramadass (Chief Technology Officer and a PDMR) on 16 July 2008 as well as to Alison Kibble (Non-Executive Director) on 31 October 2008, under the terms of the 2008 share option scheme (\"2008 Plan\"), as shown in the following table:\n \n\n\n\n\nOptionholder\n\n\nDate of Grant\n\n\nEMI Options\n\n\nNon-EMI Options\n\n\nTotal Options\n\n\nExercise Price (pence)\n\n\n\n\nChristian Hoyer Millar\n\n\n16 July 2008\n\n\n-\n\n\n1,730,742\n\n\n1,730,742\n\n\n34.0\n\n\n\n\nAlexandre Akoulitchev\n\n\n16 July 2008\n\n\n346,152\n\n\n1,096,131\n\n\n1,442,283\n\n\n34.0\n\n\n\n\nAroul Ramadass\n\n\n16 July 2008\n\n\n346,152\n\n\n1,096,131\n\n\n1,442,283\n\n\n34.0\n\n\n\n\nAlison Kibble\n\n\n31 October 2008\n\n\n-\n\n\n135,000\n\n\n135,000\n\n\n34.0\n\n\n\n\n \nThe Company also has in place the 2016 Share Option Plan (\"2016 Plan\"). No awards of options either under the 2016 Plan or otherwise have been made to any of the individuals listed above since the Company's Admission to trading on AIM on 6 December 2016. The Company confirmed its intention in the Admission Document that no new options would be granted under the 2008 Plan and any future options would be granted under the 2016 Plan and the Company re-affirms that i...